Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Drop in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large decrease in short interest in July. As of July 31st, there was short interest totaling 3,495 shares, a decrease of 63.8% from the July 15th total of 9,653 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average daily volume of 15,605 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Arcadia Biosciences Stock Up 9.6%

Shares of NASDAQ:RKDA traded up $0.05 during midday trading on Friday, reaching $0.62. The company’s stock had a trading volume of 139,968 shares, compared to its average volume of 156,549. The firm has a market cap of $1.51 million, a price-to-earnings ratio of -0.14 and a beta of 0.56. The business has a 50 day moving average price of $0.72 and a 200 day moving average price of $1.21. Arcadia Biosciences has a 1 year low of $0.50 and a 1 year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last released its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The business had revenue of $1.44 million for the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative return on equity of 144.61% and a negative net margin of 234.53%.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.